Avenue Therapeutics Investor Relations Material
Latest events
AGM 2024
Avenue Therapeutics
Q1 2025
14 May, 2025
Q4 2024
31 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Avenue Therapeutics Inc
Access all reports
Avenue Therapeutics Inc is a U.S.-based specialty pharmaceutical company focused on the development and commercialization of treatments for acute and chronic pain. The company operates in the late-stage clinical development space, advancing non-opioid and opioid pain management therapies. Its strategy includes partnering for regulatory approval and market entry. The company is headquartered in Miami, Florida, and its shares are listed on the NASDAQ.
Latest articles
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
Ticker symbol
ATXI
Country
🇺🇸 United States